Section: FRONTIERS IN
MEDICINAL CHEMISTRY
Organizing Secretary: Patrice Talaga, Ph.D.
Associate Director, Discovery Technologies
Global Chemistry, R&D, Belgium
|
INVITED LECTURES
|
The Expanding Role of NMR in the Early Steps
of Drug and Discovery
G. Bertho
Universite Paris Descartes, Equipe RMN et Modelisation,
France
|
| Triazine Derivatives as Protein a Mimetics
for the Treatment of Autoimmune Disease
Boulos Zacharie
Director of Chemistry, ProMetic Biosciences Inc.,
Canada
|
| The Use of SUR1/Kir6.2-selective Potassium
Channel Openers in the Treatment of Endocrine Metabolic
Disorders Associated with Hyperinsulinemia: Recent Developments
and Future Prospects
Bernard Pirotte
Drug Research Center, Laboratory of Medicinal Chemistry,
University of Liege, Belgium
|
| Design, Application, and Chemical Biology
of Tumor-Targeting Drug Conjugates
Iwao Ojima
Institute of Chemical Biology and Drug Discovery,
State University of New York at Stony Brook, USA
|
| Interfering with Human Thymidylate Synthase
Dimerization: A Strategy for Folate Pathway Down Regulation
in Platinum Resistant Ovarian Carcinoma
Maria Paola Costi
University of Modena and Reggio Emilia, USA
|
| Brain-Selective Estrogen Therapy
Laszlo Prokai
University of North Texas Health Science Center,
Department of Molecular Biology & Immunology, USA
|
| Oxidative Window to Alzheimer Disease Therapeutics
George Perry
Dean and Professor, College of Sciences, The University
of Texas at San Antonio, USA
|
| Retrometabolic Drug Design Strategies:
Soft Drugs and Chemical Delivery Systems
Nicholas Bodor
Center for Drug Discovery, University of Florida,
USA
|
| Discovery of Compounds Active at the Niacin
Receptor
Graeme Semple
Vice President, Discovery Chemistry, Arena Pharmaceuticals,
Inc., USA
|
|
